Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Equity Income (2022 - 2025)

INVO Fertility (IVF) has disclosed Equity Income for 4 consecutive years, with $12827.0 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Income rose 146.86% to $12827.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $26479.0, a 170.46% increase, with the full-year FY2024 number at $9045.0, up 115.01% from a year prior.
  • Equity Income was $12827.0 for Q3 2025 at INVO Fertility, up from -$19911.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $18467.0 in Q4 2024 to a low of -$117978.0 in Q2 2022.
  • A 4-year average of -$14050.8 and a median of -$8163.0 in 2023 define the central range for Equity Income.
  • Peak YoY movement for Equity Income: soared 165.58% in 2024, then plummeted 39722.0% in 2025.
  • INVO Fertility's Equity Income stood at -$21470.0 in 2022, then plummeted by 31.16% to -$28160.0 in 2023, then skyrocketed by 165.58% to $18467.0 in 2024, then plummeted by 30.54% to $12827.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Equity Income are $12827.0 (Q3 2025), -$19911.0 (Q2 2025), and $15096.0 (Q1 2025).